Su1100 ASSOCIATION BETWEEN PERIOPERATIVE GLP-1 AGONIST USE AND POST OPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING UPPER ENDOSCOPY
Leggi →
Maggio 2024
Risultati per: La nevralgia post-erpetica
Questo è quello che abbiamo trovato per te
Su1028 ETIOLOGIES AND RACIAL DIFFERENCES OF NON VARICEAL UPPER GI BLEED IN POST LIVER TRANSPLANT PATIENTS
Leggi →
Maggio 2024
Su1024 UNDERSTANDING AND MITIGATING HEALTH INEQUITIES IN POST-H. PYLORI GERD SYMPTOMS
Leggi →
Maggio 2024
Su1755 IMPACT OF BODY MASS INDEX ON CLINICAL OUTCOMES AND DRUG LEVELS IN PATIENTS WITH CROHN'S DISEASE RECEIVING MAINTENANCE TREATMENT WITH SUBCUTANEOUS INFLIXIMAB: A POST HOC ANALYSIS OF THE LIBERTY-CD STUDY
Leggi →
Maggio 2024
Sa2010 ASSESSMENT OF HEALTHDOT DEVICE FOR REAL-TIME REMOTE PATIENT MONITORING IN POST-BARIATRIC ENDOSCOPY PATIENTS: A PROSPECTIVE OBSERVATIONAL FEASIBILITY STUDY
Leggi →
Maggio 2024
Sa2012 EVALUATING THE UTILITY OF CHATGPT OVER TRADITIONAL SEARCH ENGINE QUERY FOR POST-COLONOSCOPY PATIENT CONCERNS
Leggi →
Maggio 2024
Su1635 PATIENTS WITH NONEROSIVE HEARTBURN AND EPIGATRIC PAIN SYNDROME (EPS) ARE NOT CLINICALLY DISTINGUISHABLE AND BENEFIT OF THE SAME TREATMENT. RCT POST HOC ANALYSIS DATA
Leggi →
Maggio 2024
Su1637 PREVALENCE OF GASTROPARESIS IN POST-LUNG AND LUNG/HEART TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Leggi →
Maggio 2024
Su1656 DOES LINACLOTIDE HAVE HIGH PREDICTABILITY OF DEFECATION? A POST-HOC ANALYSIS OF APPLE TRIAL.
Leggi →
Maggio 2024
Su1796 POST-MARKETING SURVEILLANCE OF TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS IN JAPAN: A FINAL REPORT OF SAFETY AND EFFECTIVENESS DATA
Leggi →
Maggio 2024
Su1454 WHY IS THE RECTAL ROUTE FOR NSAIDS FAVORABLE FOR PREVENTING POST-ERCP PANCREATITIS?
Leggi →
Maggio 2024
Su1774 RELATIONSHIP BETWEEN SYMPTOM RESOLUTION AND CLINICAL RESPONSES AFTER 12 WEEKS OF TREATMENT WITH TULISOKIBART IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A POST HOC ANALYSIS FROM ARTEMIS-UC
Leggi →
Maggio 2024
Su1773 ACHIEVEMENT OF CLINICAL AND ENDOSCOPIC OUTCOMES BY BASELINE CORTICOSTEROID USE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RECEIVED RISANKIZUMAB INDUCTION TREATMENT: A POST-HOC ANALYSIS OF THE INSPIRE STUDY
Leggi →
Maggio 2024
Su1772 EARLY CHANGE IN CDAI PREDICTS IMPROVED QUALITY OF LIFE AFTER 12-WEEK INDUCTION THERAPY WITH TULISOKIBART IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: A POST HOC ANALYSIS FROM APOLLO-CD
Leggi →
Maggio 2024
Su1770 EFFECT OF RISANKIZUMAB ON EARLY SYMPTOMS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF THE INSPIRE INDUCTION STUDY
Leggi →
Maggio 2024
Su1767 SUPER-RESPONDERS IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE TREATED WITH SUBCUTANEOUS INFLIXIMAB MAINTENANCE THERAPY: A POST HOC ANALYSIS OF THE LIBERTY-CD STUDY
Leggi →
Maggio 2024
